7S2-33071-50484
2 vaccinations
8 coded responses
24 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 957 / CA
- Registered
- 2021-05-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-12
Registered in v-safe
-
2021-05-12
Dose 1 — Moderna
-
2021-05-13
Survey response — days 1–6 daily, dose 1MedDRA: Flushing — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Facial flushingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
-
2021-05-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-05-16
- 2021-05-17
- 2021-05-18
-
2021-05-19
Health check-in — day 7, dose 1Feeling: Fair · Diarrhea · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-05-19
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-26
Survey response — day 14, dose 1MedDRA: Alopecia — Feeling: GoodFree text: Hair loss, close to postpartum amounts.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-02
-
2021-06-11
Survey response — day 28, dose 1MedDRA: Alopecia, Fatigue, Heavy menstrual bleeding, Menstrual disorder, Migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Hair loss continues, migraines worsening, fatigue and shorter heavier menstrual cycles.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-13
Dose 2 — Moderna
-
2021-06-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-06-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
-
2021-06-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-06-19
- 2021-06-20
- 2021-06-27
- 2021-07-04
- 2021-07-11
-
2021-07-18
Survey response — day 35, dose 2MedDRA: Condition aggravated, Histamine level decreased, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: MCAS flares are up in the last week even with eating low histamine and no other changes.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-25
Survey response — day 42, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: MCAS flares are frequent and more intenseMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-14
Survey response — 3 months, dose 2MedDRA: Coeliac disease, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Celiac Disease · Healthcare visit (other): Upper endoscopy scheduledMedDRA releases: 2024-11 · check-in free text available
-
2021-09-14
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-16
-
2021-12-13
Survey response — 6 months, dose 2MedDRA: Autoimmune disorder, Coeliac disease, Mast cell activation syndrome, Postural orthostatic tachycardia syndrome, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Celiac Disease, MCAS, POTS, and another undiagnosed autoimmune disorder. · Healthcare visit (other): 3 referrals to (b)(6) specialists.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-13
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-14
-
2022-06-15
Survey response — 12 months, dose 2MedDRA: Rosacea, Sinus tachycardia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Rosacea and sinus tachycardia · Healthcare visit (other): EKG, 14 day Holter Monitor, EchocardiogramMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-16
- 2022-06-16
- 2022-06-16
- 2022-06-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-12 | Moderna | |
| 2 | 2021-06-13 | Moderna |
Call center
4 call center cases
4 unsuccessful
1 wait over 3 months for a first call
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Facial flushing
Release 8 — day 14, dose 1
Symptoms: Hair loss, close to postpartum amounts.
Release 9 — day 28, dose 1
Symptoms: Hair loss continues, migraines worsening, fatigue and shorter heavier menstrual cycles.
Release 9 — day 35, dose 2
Symptoms: MCAS flares are up in the last week even with eating low histamine and no other changes.
Release 9 — day 42, dose 2
Symptoms: MCAS flares are frequent and more intense
Release 9 — 3 months, dose 2
Release 10 — 6 months, dose 2
Symptoms: Celiac Disease, MCAS, POTS, and another undiagnosed autoimmune disorder.
Healthcare visit (other): 3 referrals to (b)(6) specialists.
redacted (b)(6)
Release 12 — 12 months, dose 2
Symptoms: Rosacea and sinus tachycardia
Healthcare visit (other): EKG, 14 day Holter Monitor, Echocardiogram
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Alopecia | ✓ | ✓ | ✓ |
| SD | Autoimmune disorder | · | · | ✓ |
| SD | Coeliac disease | · | · | ✓ |
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Histamine level decreased | · | · | ✓ |
| SD | Mast cell activation syndrome | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Postural orthostatic tachycardia syndrome | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Rosacea | · | · | ✓ |
| SD | Sinus tachycardia | · | · | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release